INDEGENE LIMITED

06 May 2024 - 08 May 2024 Individual Category NSE

Min Investment

₹28380

Price Band

₹430-₹452

Issue Size

288.67 lakhs
Equity Shares

Lot Size

33 (per lot)

IPO Dates
img

06 May 2024

Open Date

img

08 May 2024

Close Date

img

09 May 2024

Allotment Date

img

13 May 2024

Listing Date

Indegene Limited IPO is open for subscription starting Monday, May 6, 2024, and closing on Wednesday, May 8, 2024. The price is decided at Rs 430 to Rs 452 per share. The minimum lot size of this IPO application for the retail category is 33 shares. The minimum lot size for small non-institutional investors is 14 lots consisting of 462 shares. Meanwhile, the minimum lot for big non-institutional investors is 68 lots with 2,244 shares. The minimum investment required for retail category investors is Rs 14,916 (452 x 33 shares). However, for small non-institutional investors, the minimum investment amount required is Rs 2,08,824 (452 x 462 shares); for big non-institutional investors, it is Rs 10,14,288 (452 x 2244 shares). Indegene IPO is a book-built issue of Rs 1,841.76 crores. The issue is a mix of fresh issue and offer-for-sale. The fresh issue consists of 1.68 crore shares amounting to Rs 760 crore. The offer for sale consists of 2.39 crore shares amounting to Rs 1,081.76 crores. The allotment for this IPO is expected to be finalised on Thursday, May 9, 2024. Indegene Limited IPO will be listed on both BSE and NSE, and the listing date is fixed on Monday, May 13, 2024. The book-running lead managers of Indegene Limited are Kotak Mahindra Capital Limited, City Group Global Market India Private Limited, J.P Morgan India Private Limited, Nomura Financial Advisory and Securities Private Limited. The registrar for this new IPO is Link Intime India Private Limited.

Know Before Investing

Strengths icon

Weaknesses icon

About Indegene Limited

Indegene Limited was founded in 1998, engaged in the business of providing digital services for the life science industry. They assist with drug development, clinical trials, regulatory submissions, pharmacovigilance, complaint management, sales and marketing support. Indegene Limited services can be divided into four major categories – Enterprise Commercial Solutions, Omnichannel activation, Enterprise Medical Solutions, Enterprise Clinical Solutions and Consultancy services. Indegene’s subsidiary DT Associates provides consultancy services under brand name DT consulting. It helps life science companies to manage their digital transportation efforts to ensure good customer experience. As per latest record available, Indegene had 65 clients actively engaged with its services. As of December 31, 2023, they had a team of 5,181 people worldwide. Out of these, 4,461 are based in India.

Founded

1998

Managing Director

-

Parent Organization

IPO Objectives

The net amount received from this Initial public offer will be used to repay/prepay the money to one of the material Subsidiaries, ILSL Holdings. The remaining will be used to fund the W.C requirements. Moreover, the IPO amount will be utilised in general corporate purposes and inorganic growth. 

Company Promoters

Subscription Details

Investor Category Subscription (times)
Qualified Institutions 0
Non-Institutional Buyers 0
bNII (bids above ₹10L) 0
sNII (bids below ₹10L) 0
Retail Investors 0
Employees 0
Others 0
Total 0
img

How to Apply for IPO

img img

Login

Login to your Bigul Account

Select Lots & Price

Choose the number of lots and price

UPI ID

Enter your UPI ID

UPI Mandate Request

A UPI Mandate Request Triggered

Approve Mandate

Approve the UPI Mandate Request

IPO Allotment

YES Share will be credited. and the amount will be debited

Close

Let's Open Free Demat Account